Abiopharma

🔍 Aurora Daljit Singh (Executive)

Company: Neumora Therapeutics, Inc. (NMRA)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 67,741 shares of Common Stock at $0.72 per share (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: false | shares_owned_after: 116,491.00 | transaction_form_type: 4
• Sold 67,741 shares of Common Stock at $1.5144 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: false | shares_owned_after: 48,750.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 21,685 shares of Common Stock at $0.72 per share (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: false | shares_owned_after: 21,685.00 | transaction_form_type: 4 | Footnotes: F3
• Acquired 45,026 shares of Common Stock at $0.72 per share (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: false | shares_owned_after: 66,711.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 66,711 shares of Common Stock at $1.514 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2, F3
• Acquired 20,553 shares of Common Stock at $0.72 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: false | shares_owned_after: 69,303.00 | transaction_form_type: 4
• Sold 20,553 shares of Common Stock at $1.5949 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | shares_owned_after: 48,750.00 | transaction_form_type: 4 | Footnotes: F7
• Acquired 21,055 shares of Common Stock at $0.72 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: false | shares_owned_after: 21,055.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 21,055 shares of Common Stock at $1.5958 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F8, F3
• Sold 67,741 shares of Stock Option (Right to Buy) at $0.72 per share (Derivative)
  Date: 2026-08-20 | Code: M | Expires: 2034-02-14 | equity_swap_involved: false | shares_owned_after: 109,527.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 45,026 shares of Stock Option (Right to Buy) at $0.72 per share (Derivative)
  Date: 2026-08-20 | Code: M | Expires: 2033-01-19 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F5, F3
• Sold 21,685 shares of Stock Option (Right to Buy) at $0.72 per share (Derivative)
  Date: 2026-08-20 | Code: M | Expires: 2031-09-20 | equity_swap_involved: false | shares_owned_after: 115,853.00 | transaction_form_type: 4 | Footnotes: F5, F3
• Acquired 200,000 shares of Stock Option (Right to Buy) at $1.52 per share (Derivative)
  Date: 2026-08-20 | Code: A | Expires: 2036-08-20 | equity_swap_involved: false | shares_owned_after: 200,000.00 | transaction_form_type: 4 | Footnotes: F6
• Sold 20,553 shares of Stock Option (Right to Buy) at $0.72 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2034-02-14 | equity_swap_involved: false | shares_owned_after: 88,974.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 21,055 shares of Stock Option (Right to Buy) at $0.72 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2031-09-20 | equity_swap_involved: false | shares_owned_after: 94,798.00 | transaction_form_type: 4 | Footnotes: F5, F3

Footnotes:

• F1: This transaction was executed in multiple trades at prices ranging from $1.485 to $1.625, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F2: This transaction was executed in multiple trades at prices ranging from $1.48 to $1.6252, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F3: Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries.
• F4: 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
• F5: The stock option is fully vested and exercisable.
• F6: 25% of the shares subject to the option vest on the first anniversary measured from August 20, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
• F7: This transaction was executed in multiple trades at prices ranging from $1.51 to $1.6379, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F8: This transaction was executed in multiple trades at prices ranging from $1.51 to $1.6393, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• REMARKS: Title: Chief Operating and Development Officer